Merck tries to lock in generic HIV pill access, but Latin America is still uncertain
Generic versions in Africa and India could cost as little as $5 per person per year, while access in Latin America remains unclear.
By Faisal Al-Qahtani·· 3 min
Loading the Newsroom
Curating from trusted global sources…